Invivyd (IVVD) Depreciation & Amortization (CF) (2021 - 2025)
Invivyd posted quarterly Depreciation & Amortization (CF) of $149000.0 for Q4 2025, down 86.25% year-on-year from $1.1 million in Q4 2024, and little changed on a QoQ basis from $149000.0 in Q3 2025.
Invivyd (IVVD) has 5 years of Depreciation & Amortization (CF) data on file, last reported at $149000.0 in Q4 2025.
- For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 86.25% year-over-year to $149000.0; the trailing twelve-month figure through Dec 2025 stood at $755000.0 (down 48.5% YoY), and the FY2025 full-year result was $755000.0, down 48.5% from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 stood at $149000.0, roughly flat from $149000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1.1 million in Q4 2024 and bottomed at $1000.0 in Q4 2021.
- The 5-year median for Depreciation & Amortization (CF) is $121000.0 (2023), against an average of $161352.9.
- The widest annual swing landed in 2023, when Depreciation & Amortization (CF) soared 2900.0%; it then tumbled 86.25% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $1000.0 in 2021, then soared by 2600.0% to $27000.0 in 2022, then soared by 344.44% to $120000.0 in 2023, then soared by 803.33% to $1.1 million in 2024, then sank by 86.25% to $149000.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $149000.0 (Q4 2025), $149000.0 (Q3 2025), and $151000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Invivyd | 208.38 Mn | -18.31 Mn | - | 149,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 149,000.00 |
| Dec 31, 2025 | 149,000.00 |
| Sep 30, 2025 | 149,000.00 |
| Sep 30, 2025 | 149,000.00 |
| Jun 30, 2025 | 151,000.00 |
| Jun 30, 2025 | 151,000.00 |
| Mar 31, 2025 | 306,000.00 |
| Mar 31, 2025 | 306,000.00 |
| Dec 31, 2024 | 1.08 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 132,000.00 |
| Sep 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 128,000.00 |
| Jun 30, 2024 | 128,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Dec 31, 2023 | 120,000.00 |
| Dec 31, 2023 | 120,000.00 |
| Sep 30, 2023 | 119,000.00 |
| Sep 30, 2023 | 119,000.00 |
| Jun 30, 2023 | 121,000.00 |
| Jun 30, 2023 | 121,000.00 |
| Mar 31, 2023 | 120,000.00 |
| Mar 31, 2023 | 120,000.00 |
| Dec 31, 2022 | 27,000.00 |
| Dec 31, 2022 | 27,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |